<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>14</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Anti-proliferative Activities of Metallic Nanoparticles in an in Vitro Breast Cancer Model</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>6039</FirstPage>
			<LastPage>6046</LastPage>
			<ELocationID EIdType="pii">31368</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Aims: To investigate effect of metallic nanoparticles, silver (AgNPs) and gold nanoparticles (AuNPs) asantitumor treatment in vitro against human breast cancer cells (MCF-7) and their associated mechanisms. Thiscould provide new class of engineered nanoparticles with desired physicochemical properties and may presentnewer approaches for therapeutic modalities to breast cancer in women. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: A humanbreast cancer cell line (MCF-7) was used as a model of cells. Metallic nanoparticles were characterized usingUV-visible spectra and transmission electron microscopy (TEM). Cytotoxic effects of metallic nanoparticles onMCF-7 cells were followed by colorimetric SRB cell viability assays, microscopy, and cellular uptake. Natureof cell death was further investigated by DNA analysis and flow cytometry. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Treatment of MCF-7 withdifferent concentrations of 5-10nm diameter of AgNPs inhibited cell viability in a dose-dependent manner, withIC50 value of 6.28μM, whereas treatment of MCF-7 with different concentrations of 13-15nm diameter of AuNPsinhibited cell viability in a dose-dependent manner, with IC50 value of 14.48μM. Treatment of cells with a IC50concentration of AgNPs generated progressive accumulation of cells in the S phase of the cell cycle and preventedentry into the M phase. The treatment of cells with IC50 concentrations of AuNPs similarly generated progressiveaccumulation of cells in sub-G1 and S phase, and inhibited the entrance of cells into the M phase of the cell cycle.DNA fragmentation, as demonstrated by electrophoresis, indicated induction of apoptosis. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: Ourengineered silver nanoparticles effectively inhibit the proliferation of human breast carcinoma cell line MCF-7in vitro at high concentration (1000 μM) through apoptotic mechanisms, and may be a beneficial agent againsthuman carcinoma but further detailed study is still needed.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Metallic nanoparticles</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">anti-proliferative activity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Breast cancer cell line</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cytotoxicity</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_31368_8aa4d566d5c92da592c93de2327942ae.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
